Mucosal mast cells are pivotal elements in inflammatory bowel disease that connect the dots: Stress, intestinal hyperpermeability and inflammation

被引:97
作者
Farhadi, Ashkan [1 ]
Fields, Jeremy Z. [1 ]
Keshavarzian, Ali [1 ]
机构
[1] Rush Univ, Med Ctr, Div Digest Dis & Nutr, Chicago, IL 60612 USA
关键词
mast cells; intestinal permeability; stress; inflammatory bowel disease; irritable bowel syndrome; intestinal barrier;
D O I
10.3748/wjg.v13.i22.3027
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Mast cells (MC) are pivotal elements in several physiological and immunological functions of the gastrointestinal (GI) tract. MC translate the stress signals that has been transmitted through brain gut axis into release of proinflammatory mediators that can cause stimulation of nerve endings that could affect afferent nerve terminals and change their perception, affect intestinal motility increase intestinal hyperpermeability and, in susceptible individuals, modulate the inflammation. Thus, it is not surprising that MC are an important element in the pathogenesis of inflammatory bowel disease and non inflammatory GI disorders such as IBS and mast cell enterocolitis. (c) 2007 The WJG Press. All rights reserved.
引用
收藏
页码:3027 / 3030
页数:4
相关论文
共 46 条
[1]
Anton P A, 1999, Semin Gastrointest Dis, V10, P14
[2]
Activated mast cells in proximity to colonic nerves correlate with abdominal pain in irritable bowel syndrome [J].
Barbara, G ;
Stanghellini, V ;
De Giorgio, R ;
Cremon, C ;
Cottrell, GS ;
Santini, D ;
Pasquinelli, G ;
Morselli-Labate, AM ;
Grady, EF ;
Bunnett, NW ;
Collins, SM ;
Corinalidesi, R .
GASTROENTEROLOGY, 2004, 126 (03) :693-702
[3]
New pathophysiological mechanisms in irritable bowel syndrome [J].
Barbara, G ;
De Giorgio, R ;
Stanghellini, V ;
Cremon, C ;
Salvioli, B ;
Corinaldesi, R .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2004, 20 :1-9
[4]
Functional gastrointestinal disorders and mast cells: implications for therapy [J].
Barbara, G ;
Stanghellini, V ;
De Giorgio, R ;
Corinaldesi, R .
NEUROGASTROENTEROLOGY AND MOTILITY, 2006, 18 (01) :6-17
[5]
Quantitative assessment of intestinal eosinophils and mast cells in inflammatory bowel disease [J].
Bischoff, SC ;
Wedemeyer, J ;
Herrmann, A ;
Meier, PN ;
Trautwein, C ;
Cetin, Y ;
Maschek, H ;
Stolte, M ;
Gebel, M ;
Manns, MP .
HISTOPATHOLOGY, 1996, 28 (01) :1-13
[6]
INTESTINAL PERMEABILITY - AN OVERVIEW [J].
BJARNASON, I ;
MACPHERSON, A ;
HOLLANDER, D .
GASTROENTEROLOGY, 1995, 108 (05) :1566-1581
[7]
TOPICAL TREATMENT OF ULCERATIVE PROCTITIS WITH LIDOCAINE [J].
BJORCK, S ;
DAHLSTROM, A ;
AHLMAN, H .
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 1989, 24 (09) :1061-1072
[8]
Treatment of distal colitis with local anaesthetic agents [J].
Björck, S ;
Dahlström, A ;
Ahlman, H .
PHARMACOLOGY & TOXICOLOGY, 2002, 90 (04) :173-180
[9]
PAR2 activation alters colonic paracellular permeability in mice via IFN-γ-dependent and -independent pathways [J].
Cenac, N ;
Chin, AC ;
Garcia-Villar, R ;
Salvador-Cartier, C ;
Ferrier, L ;
Vergnolle, N ;
Buret, AG ;
Fioramonti, J ;
Bueno, L .
JOURNAL OF PHYSIOLOGY-LONDON, 2004, 558 (03) :913-925
[10]
Induction of intestinal inflammation in mouse by activation of proteinase-activated receptor-2 [J].
Cenac, N ;
Coelho, AM ;
Nguyen, C ;
Compton, S ;
Andrade-Gordon, P ;
MacNaughton, WK ;
Wallace, JL ;
Hollenberg, MD ;
Bunnett, NW ;
Garcia-Villar, R ;
Bueno, L ;
Vergnolle, N .
AMERICAN JOURNAL OF PATHOLOGY, 2002, 161 (05) :1903-1915